KZR Kezar Life Sciences, Inc. Stock Quote

KZR [NASD]

Index	-	P/E	-	EPS (ttm)	-1.04	Insider Own	2.20%	Shs Outstand	60.63M	Perf Week	-0.54%
Market Cap	318.31M	Forward P/E	-	EPS next Y	-1.21	Insider Trans	6.25%	Shs Float	49.84M	Perf Month	-63.18%
Income	-54.60M	PEG	-	EPS next Q	-0.29	Inst Own	71.50%	Short Float	8.48%	Perf Quarter	-61.93%
Sales	-	P/S	-	EPS this Y	-9.20%	Inst Trans	4.08%	Short Ratio	4.22	Perf Half Y	-57.11%
Book/sh	3.83	P/B	1.43	EPS next Y	-29.60%	ROA	-31.20%	Target Price	18.00	Perf Year	-8.19%
Cash/sh	4.18	P/C	1.31	EPS next 5Y	-	ROE	-34.00%	52W Range	4.61 - 18.55	Perf YTD	-67.17%
Dividend	-	P/FCF	-	EPS past 5Y	-16.10%	ROI	-	52W High	-70.40%	Beta	0.73
Dividend %	-	Quick Ratio	35.30	Sales past 5Y	-	Gross Margin	-	52W Low	19.09%	ATR	0.86
Employees	56	Current Ratio	35.30	Sales Q/Q	-	Oper. Margin	-	RSI (14)	23.37	Volatility	9.79% 9.21%
Optionable	Yes	Debt/Eq	0.04	EPS Q/Q	-3.90%	Profit Margin	-	Rel Volume	1.67	Prev Close	5.49
Shortable	Yes	LT Debt/Eq	0.04	Earnings	-	Payout	-	Avg Volume	1.00M	Price	5.49
Recom	1.70	SMA20	-36.65%	SMA50	-57.63%	SMA200	-52.29%	Volume	0	Change	0.00%

Dec-08-21

Initiated

Wells Fargo

Overweight

$19

Jul-16-18

Initiated

William Blair

Outperform

Jul-16-18

Initiated

Wells Fargo

Outperform

$30

Jul-16-18

Initiated

Jefferies

Buy

May-12-22 04:01PM	Kezar Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update Business Wire
May-11-22 09:32AM	Health Check: How Prudently Does Kezar Life Sciences (NASDAQ:KZR) Use Debt? Simply Wall St.
08:59AM	10 Stocks to Invest in Under $20 According to Michael Castors Sio Capital Insider Monkey
May-10-22 08:38AM	Should You Buy Kezar (KZR) Ahead of Earnings? Zacks
May-05-22 04:30PM	Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire -7.33%
May-04-22 03:57PM	Wells Fargo Analyst Has Questions On Kezar's Lupus Nephritis Data Readout, Stock Plunges Benzinga -43.51%
05:57AM	Kezar Life's Lead Asset Fails To Top Placebo In Muscle Inflammation Disease Benzinga
May-03-22 04:01PM	Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis Business Wire
Apr-15-22 04:05PM	Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Apr-05-22 07:00AM	VOX PROVIDES DEVELOPMENT & EXPLORATION UPDATES CNW Group
Mar-24-22 11:03AM	3 Strong Buy Stocks Showing Strong Insider Interest TipRanks
Mar-23-22 04:58PM	Possible turnaround for Kezar Life Sciences, Inc. (NASDAQ:KZR) insiders, still down US$17k after a US$1.3m shopping spree Simply Wall St. +9.48%
Mar-18-22 12:42PM	Stocks Mostly Higher As FedEx, Biotech, Chipmakers Report News, Earnings Investor's Business Daily
Mar-17-22 04:01PM	Kezar Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update Business Wire
Mar-02-22 07:00AM	Kezar Life Sciences to Participate in Cowen 42nd Annual Health Care Conference Business Wire
Dec-28-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com
Dec-21-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com
Dec-16-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com +8.05%
Dec-10-21 07:00AM	Kezar Appoints Courtney Wallace to its Board of Directors Business Wire
Dec-09-21 06:05PM	3 Monster Growth Stocks That Can Rip Higher TipRanks -6.03%
Dec-08-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... GuruFocus.com
Nov-16-21 12:07PM	Mid-Day Market Update: Crude Oil Down 1%; Kezar Life Sciences Shares Surge Benzinga +37.81%
11:38AM	Why Kezar Life Sciences Stock Is Soaring Today Motley Fool
07:27AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday InvestorPlace
06:02AM	Small-cap Biopharma Kezar Life Sciences Is Soaring, Here's Why Benzinga
Nov-15-21 04:05PM	Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus Nephritis Business Wire
Nov-11-21 07:00AM	Kezar Life Sciences to Present at the Jefferies London Healthcare Conference Business Wire
Nov-10-21 09:47AM	Oxford Finance Provides $50 Million Credit Facility to Kezar Life Sciences, Inc. Business Wire
Nov-09-21 04:05PM	Kezar Reports Third Quarter Financial Results and Provides Business Update Business Wire
Nov-03-21 08:00AM	Kezar to Host Virtual Investor and Analyst Day on November 15, 2021 Business Wire +7.22%
Oct-27-21 08:00AM	Kezar Announces First Patient Dosed in Phase 1 Trial of KZR-261 in Advanced Solid Tumor Malignancies Business Wire -5.58%
Oct-25-21 10:33AM	Companies Like Kezar Life Sciences (NASDAQ:KZR) Are In A Position To Invest In Growth Simply Wall St.
Oct-15-21 02:12PM	10 Pharmaceutical Stocks to Buy According to Lawrence Hawkins Prosight Capital Insider Monkey
Oct-05-21 04:01PM	Kezar Life Sciences Appoints Gitanjali Jain as Vice President, Investor Relations and External Affairs Business Wire
Sep-21-21 02:34PM	3 Hot Growth Stocks to Beat the Market Volatility TipRanks
Sep-02-21 07:00AM	Kezar Life Sciences to Participate in Two Upcoming Investor Conferences Business Wire
Aug-23-21 07:01AM	Kezar Life Sciences Announces Completion of Enrollment of Its Phase 2 PRESIDIO Clinical Trial of KZR-616 in Polymyositis and Dermatomyositis Business Wire +13.21%
Aug-12-21 04:02PM	Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates Business Wire
Jul-26-21 04:52AM	Could The Kezar Life Sciences, Inc. (NASDAQ:KZR) Ownership Structure Tell Us Something Useful? Simply Wall St.
Jul-08-21 07:01AM	Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021 Business Wire
Jun-08-21 07:01AM	Kezar Life Sciences Announces Formation of Clinical Advisory Committee Business Wire
Jun-02-21 07:01AM	Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021 Business Wire
Jun-01-21 04:01PM	Kezar Appoints Rheumatology Industry Expert, Micki Klearman, MD, to its Board of Directors Business Wire
May-27-21 07:00AM	Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference Business Wire
May-26-21 04:01PM	Kezar Life Sciences to Host Virtual MISSION Phase 1b Data Update Call at EULAR 2021 on June 2, 2021 Business Wire
May-12-21 04:01PM	Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates Business Wire
May-10-21 04:01PM	Kezar Life Sciences Recognized as 2021 Bay Area Best Places to Work Business Wire -6.79%
Apr-19-21 06:45AM	We're Hopeful That Kezar Life Sciences (NASDAQ:KZR) Will Use Its Cash Wisely Simply Wall St.
Apr-10-21 08:30AM	Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting Business Wire
Feb-25-21 04:01PM	Kezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care Conference Business Wire
Feb-16-21 12:53AM	What Kind Of Investors Own Most Of Kezar Life Sciences, Inc. (NASDAQ:KZR)? Simply Wall St.
Feb-10-21 04:01PM	Kezar Life Sciences to Present at BIO CEO & Investor Digital Conference Business Wire +13.84%
Jan-07-21 04:02PM	Kezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference Business Wire
Dec-18-20 03:13AM	Kezar Life Sciences, Inc. (NASDAQ:KZR) Insiders Increased Their Holdings Simply Wall St.
Dec-15-20 07:52AM	The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga
Dec-14-20 04:01PM	Kezar Life Sciences Added to the Nasdaq Biotechnology Index Business Wire
10:46AM	Is KZR A Good Stock To Buy Now? Insider Monkey
Nov-12-20 04:05PM	Kezar Life Sciences to Present During Upcoming Virtual Investor Conferences Business Wire
Nov-05-20 04:01PM	Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates Business Wire
08:46AM	Kezar Highlights Broad Therapeutic Potential of KZR-616 During ACR Convergence 2020 Business Wire
Oct-23-20 07:26AM	The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO Benzinga
07:00AM	Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and Dermatomyositis Business Wire
Oct-19-20 02:25PM	We're Not Very Worried About Kezar Life Sciences' (NASDAQ:KZR) Cash Burn Rate Simply Wall St.
Oct-15-20 07:00AM	Kezar Life Sciences to Present at Four Upcoming Virtual Medical and Scientific Conferences Business Wire
Sep-18-20 07:30AM	The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations Benzinga
Sep-17-20 04:01PM	Kezar Highlights Data from MISSION Phase 1b Study of KZR-616 during the Pan American Congress of Rheumatology Business Wire
Sep-10-20 07:00AM	Kezar Life Sciences to Present at The Myositis Association International Annual Patient Conference and the Pan-American Congress of Rheumatology Business Wire
Aug-11-20 08:59AM	What Is The Ownership Structure Like For Kezar Life Sciences, Inc. (NASDAQ:KZR)? Simply Wall St.
08:53AM	Is Kezar Life Sciences, Inc.'s (NASDAQ:KZR) Shareholder Ownership Skewed Towards Insiders? Simply Wall St.
Aug-05-20 04:01PM	Kezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update Business Wire
Aug-03-20 04:01PM	Kezar Life Sciences to Participate in Two Upcoming Virtual Investor Conferences Business Wire
Jul-29-20 05:17PM	Kezar Life Sciences to Release Second Quarter Financial Results and General Business Updates on August 5, 2020 Business Wire
Jun-23-20 09:16PM	Kezar Life Sciences, Inc. (KZR): Hedge Funds In Wait-and-See Mode Insider Monkey
Jun-16-20 09:36AM	Billionaire Ken Griffin Pulls the Trigger on These 3 Penny Stocks TipRanks +5.24%
Jun-12-20 07:01AM	Trade Alert: The Independent Director Of Kezar Life Sciences, Inc. (NASDAQ:KZR), Franklin Berger, Has Just Spent US$550k Buying 15% More Shares Simply Wall St.
Jun-09-20 04:15PM	Why Kezar Life Sciences Is Down Today Motley Fool -12.14%
11:15AM	Is This Flaming Hot Biotech Stock a Buy? Motley Fool
Jun-08-20 08:48PM	Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock and Pre-Funded Warrants GlobeNewswire -9.01%
06:00AM	Kezar Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-03-20 04:02PM	Kezar Provides Data Update from MISSION Study of KZR-616 GlobeNewswire -8.21%
May-28-20 04:01PM	Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference GlobeNewswire
May-20-20 04:42PM	Kezar Announces Presentations During Upcoming Scientific Conferences GlobeNewswire +7.48%
May-11-20 10:35AM	Why Earnings Season Could Be Great for Kezar Life Sciences (KZR) Zacks
09:52AM	Top Ranked Momentum Stocks to Buy for May 11th Zacks
08:35AM	We're Not Very Worried About Kezar Life Sciences's (NASDAQ:KZR) Cash Burn Rate Simply Wall St.
06:56AM	H.C. Wainwright Sticks to Their Buy Rating for Kezar Life Sciences Inc Investing.com
May-07-20 04:01PM	Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire +16.70%
May-04-20 04:01PM	Kezar Life Sciences Strengthens Executive Team with the Appointment of Noreen R. Henig, MD as Chief Medical Officer GlobeNewswire +13.16%
Apr-09-20 06:08PM	Clinical trials in the age of COVID: Shelter-in-place, hospital restrictions cause drug study delays American City Business Journals +9.66%
07:00AM	Kezar Provides Statement Regarding COVID-19 Pandemic GlobeNewswire
Mar-24-20 11:30AM	Is Kezar Life Sciences (KZR) Stock Outpacing Its Medical Peers This Year? Zacks +5.38%
Mar-12-20 04:01PM	Kezar Life Sciences Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update GlobeNewswire -13.28%
Feb-26-20 04:01PM	Kezar Life Sciences to Present at Cowen and Companys 40th Annual Healthcare Conference GlobeNewswire
Feb-07-20 08:36AM	Franklin Berger Is The Independent Director of Kezar Life Sciences, Inc. (NASDAQ:KZR) And They Just Spent US$314k On Shares Simply Wall St.
Feb-04-20 05:50PM	Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire
12:04PM	Wall Street Recommends Picking Up These Falling Knives GuruFocus.com
Jan-31-20 08:13AM	Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire +10.83%
Dec-19-19 07:00AM	Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors GlobeNewswire +6.27%
Dec-16-19 07:29AM	Hedge Funds Are Selling Kezar Life Sciences, Inc. (KZR) Insider Monkey
Dec-09-19 04:05PM	Kezar Life Sciences Highlights Therapeutic Potential of Protein Secretion Inhibitors at the 61st American Society of Hematology Annual Meeting GlobeNewswire

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and autoimmunity. The company was founded in 2015 and is based in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BERGER FRANKLIN M	Director	Mar 21	Buy	14.77	20,000	295,400	890,691	Mar 22 05:45 PM
BERGER FRANKLIN M	Director	Mar 18	Buy	16.74	60,000	1,004,400	870,691	Mar 22 05:45 PM
Kauffman Michael	Director	Jan 03	Option Exercise	5.91	5,000	29,550	68,690	Jan 05 06:51 PM
Kauffman Michael	Director	Jan 03	Sale	16.45	5,000	82,250	63,690	Jan 05 06:51 PM
Fowler John Franklin	CEO	Dec 14	Option Exercise	0.90	7,700	6,930	366,904	Dec 15 06:05 PM
BERGER FRANKLIN M	Director	Sep 22	Option Exercise	5.60	8,896	49,818	810,691	Sep 23 04:26 PM
BERGER FRANKLIN M	Director	Sep 21	Option Exercise	6.77	17,792	120,452	801,795	Sep 23 04:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience